CClinicalTrials.gg
CompletedNCT07140354tcSCSUpdated Aug 24, 2025

Regain of Arm and Hand Movements in Cervical Spinal Stimulation

An interventional study of cervical transcutaneous spinal cord stimulation in Spinal Cord Injuries, sponsored by Institut Guttmann. Completed at 1 site in Spain. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by Institut Guttmann · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 11 months after the study started (first participant enrolled Sep 2020, registered Aug 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

We will develop a "bottom to top" approach employing animal models and human testing to determine whether or not non-invasive neuro-modulation of the cervical spinal cord concomitant with upper limb rehabilitation driven by exo-skeletons can facilitate the regain of the arm and hand functional movements in spinal cord injured patients.

We hypothesize that that spinal electrical neuro-modulation together with sensory-motor rehabilitation will facilitate the transmission and processing of the motor commands along the residual brain-to-spinal connectome leading to the regain of arm and hand movements. The proposal follows a multi-disciplinary and translational approach; including basic scientists, engineers and clinicians, and is divided in 3 independent but related working packages (WP). WP1: Develop of a selfcontained hybrid robotic system to drive arm and hand movements rehabilitation in spinal cord injured patients. WP2: Implement the exo-skeleton to rehabilitate arm and hand movements concomitant to cervical electrical neuro-modulation in cervical spinal cord inured patients. WP3: In an animal model, using the optimal spinal stimulation parameters, identify the cellular and molecular changes in the brain-to-spinal connectome, which mediates recovery.

The results will support the development of the first feasible treatment to improve manual dexterity in cervical spinal cord inured patients, and will present a comprehensive and detailed analysis of the mechanisms underlying the recovery, providing an indispensable guideline for the application of stimulation-based therapy to SCI patients.

This proposal is a continuation of a recently awarded grant (2017-2020, funded by "Instituto Carlos III"), intended to obtain the optimal stimulation parameters to effectively neuromodulate the cervical spinal cord and facilitate arm function. The present proposal is the natural step forward, in which we want to explore in depth the mechanisms underpinning recovery, and further strength the rehabilitation intervention with arm exo

-skeleton, which will allow the performance of movements in severely injured patients.

Read the detailed description

Patient selection criteria: The study will consist of two populations of patients: Population A will include a total of 10-15 patients with an incomplete cervical lesion (ASIA C and D), and a population B, with 8-15 patients with a complete motor cervical injury (ASIA A and B). Patients from both populations will have ages between 18 and 60 years, with a level of injury between C5 and T1 and with more than 12 months of evolution since the onset of the injury.

Experimental design:

Selected patients from both populations (A and B) will be included in one of the following groups: Group 1: Patients will receive conventional sensory-motor rehabilitation regimen of the upper limb concomitant; Group 2. Patients will receive conventional rehabilitation concomitant with transcutaneous electrical stimulation. Group 3: Patients will have exo-skeleton driven arm rehabilitation concomitant with transcutaneous electrical stimulation. Each session will last 40 minutes and will be done daily during the 6 weeks of evaluation.

Cervical transcutaneous stimulation protocol: Transcutaneous electrical stimulation will be applied by an external set of electrodes, which will be placed on the skin in the midline between the spinous processes of C6 and C8. Two rectangular plates (5.0 x 10.2 cm2) are placed on the skin of the shoulder blades and act as anodes. The electrical stimulation consist of monopolar pulse trains of 1 millisecond duration, released at a frequency of 10 kHz and at an intensity ranging from 80 to 180 mA. Each pulse train is presented at a frequency of 100Hz (ref 8). The stimulation intensity will be adjusted to 90% of the threshold to evoke contractions of the muscles. Rehabilitation of the upper limb. Conventional rehabilitation consists in voluntary, or assisted by a physical therapist, to manually articulate the upper extremities. Patients will perform motor and voluntary rehabilitation of the arms and hands to manipulate objects, performing exercises of grip, endurance and dexterity (ref 9) Robotic upper limb rehabilitation program.

By means of custom-made robotic exo-skeleton patients will move a joystick by a board, following a pattern presented on a television screen. The robot has a sensory feed back system, by which the regain of voluntary movements by the patients will decrease the force exerted by the exo-skeleton to move the arm. Patients will be included in the same number and length of sessions as the conventional rehabilitation regime. Neurological and functional evaluation. To evaluate the effectiveness of the intervention, prior to the initiation of rehabilitation, and once a month until the end of the study, a series of neurological, functional and daily life activities (ref 10) will be performed to evaluate the Effects of spinal stimulation on the motor control of the arms and hands. In addition, prior to the start and the end of each program, motor evoked potentials will be evaluated from the motor cortex and the monoand poly-synaptic reflexes evoked after peripheral nerve stimulation, in order to evaluate the acute and long-term changes in The cortico-medullary and own-medullary connectivity induced by the electrical stimulation.

Data analysis. Each patient will have previous and post-stimulation data. We will evaluate t-test between the different conditions, for each neurological and functional variable evaluated.

02

Conditions studied

  • Spinal Cord Injuries

Keywords

  • spinal cord injuries
  • cervical neuromodulation
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 40 is above the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Institut Guttmann is the lead sponsor of 18 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • male or female, more than 18 years old;
  • a stable traumatic or no traumatic cervical SCI
  • time since SCI: 3-12 months
  • AIS A, B, C, and D with but at least ≥ 2 muscles affected in the upper extremities, with a total sum of muscle strength more than 2 points in two muscles (the wrist extension together with abductor pollicis brevis (APB) at least in one side).

Exclusion criteria

Exclusion Criteria:

  • unstable medical condition (cancer, acute infections, etc.)
  • dependent on mechanical ventilation
  • severe spasticity (≥3 score on the Modified Ashworth scale-MAS)
  • contraindication for rehabilitation assisted with a robotic exoskeleton (Armeo®Power)
  • peripheral nerve injury
  • intolerance of tSCS, peacemakers, electronic implants, or episodes of epilepsy
  • participating in another investigation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    tcSCS group

    The SCI individuals will receive transcutaneous Spinal Cord Stimulation (tcSCS) at the cervical level during upper extremity Ocupational therapy including ARMEO robotic therapy

    Device: cervical transcutaneous spinal cord stimulation

  • Placebo comparator
    control group

    In the control group the SCI individuals will realize their routine ocupational therapy including ARMEO robotic therapywithout tSCS

    Device: cervical transcutaneous spinal cord stimulation

Interventions

  • Devicecervical transcutaneous spinal cord stimulation

    Cervical transcutaneous spinal cord stimulation (tSCS) delivers electrical currents over the cervical spinal cord to modulate neural circuits controlling the upper extremities. This approach has been shown to facilitate motor output, improve hand and arm function, and promote neuroplasticity in individuals with cervical spinal cord injury.

06

What researchers measure

Primary outcomes

  1. GRASSP

    The Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) is a standardized clinical tool designed to evaluate upper limb function in individuals with cervical spinal cord injury. It assesses strength, sensory function, and hand prehension ability to provide a comprehensive measure of hand and arm impairment.

    Time frame: 2-3HRS

  2. MVC of upper extremity

    Maximum Voluntary Contraction (MVC) of the upper extremity refers to the greatest amount of force that a person can voluntarily generate with a specific muscle or muscle group of the arm or hand during an isometric contraction. It is commonly used as a standardized measure of muscle strength in research and rehabilitation, often recorded with devices such as dynamometers or force transducers.

    Time frame: 40-50MIN

Secondary outcomes

  1. UEMS

    The Upper Extremity Motor Score (UEMS) is a component of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) used to assess motor function in the upper limbs. It is calculated by testing five key muscle groups on each side (C5-T1), with scores ranging from 0 (total paralysis) to 5 (normal strength), for a maximum of 25 per side and 50 in total.

    Time frame: 15-20min

  2. Spirometry for respiratory function

    Spirometry is a standardized pulmonary function test used to assess respiratory function by measuring airflow and lung volumes during forced breathing maneuvers. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV₁), and the FEV₁/FVC ratio, which provide information on restrictive and obstructive ventilatory patterns.

    Time frame: 20-30min

  3. MIP and MEP

    ChatGPT Plus Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) are non-invasive measures of respiratory muscle strength.

    Time frame: 20-30min

Other outcomes

  1. Quality of life measured by WhoQol-Bref

    Quality of life was measured by WhoQol-Bref based on a four-domain structure: physical health, psychological, social relationships, environment, and two questions about an individual's overall perception of their health.

    Time frame: 20-30min

07

Study locations

1 site
  • Institut Guttmann
    Badalona, Barcelona 08916, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07140354
Lead sponsor
Institut Guttmann
Responsible party
Joan Vidal (Regain of arm and hand movements in cervical spinal cord injury patients by means of spinal electrical neuromodulation assisted with an arm exoskeleton., Institut Guttmann) — Principal investigator
First posted
Aug 24, 2025
Start date
Sep 1, 2020
Primary completion
Mar 1, 2024
Completion
Sep 8, 2024
Last update
Aug 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion